---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-000805"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T08:59:12.293126+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience issues 191,698 shares, raises ~$1.5M from accredited investor since Nov 2024

## Summary
- Sold 75,000 shares at $20.19 each to one accredited investor, gross proceeds ~$1.5M.
- Granted 38,478 restricted shares to non-employee directors under 2024 Equity Incentive Plan.
- Issued 78,320 shares to investors under Exchange Program in exchange for cancellation of co-development agreements.
- Total shares outstanding as of Jan 20, 2025: 3,738,033.
- Shares issued in unregistered transactions exempt under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001654954-25-000805
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495425000805/0001654954-25-000805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495425000805/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-000805
- JSON: https://secwatch.observer/filing/0001654954-25-000805.json
- Plain text: https://secwatch.observer/filing/0001654954-25-000805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.